Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Advanced Biomed Inc. (ADVB : NSDQ)

• Company Description    Advanced Biomed Inc. is a biotechnology company focused on early screening and detection, diagnosis and staging and treatment of cancer. Advanced Biomed Inc. is based in Tainan, Taiwan. Number of Employees: 18

• Price / Volume Information    Yesterday's Closing Price: $3.76 Daily Weekly Monthly 20 Day Moving Average: 38,296 shares Shares Outstanding: 1.65 (millions) Market Capitalization: $6.21 (millions) Beta: 0.01 52 Week High: $24.23 52 Week Low: $3.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -40.51% -40.90% 12 Week -65.76% -67.70% Year To Date -35.57% -43.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12th Floor Tower 1 W MEGA Non. 252 Texaco Road and No. 28 Wang Lung Street - Hong Kong,K3 00000 HKG ph: 852-3158-0999 fax: - services@wfsir.com http://www.advanbiomed.com

• General Corporate Information    Officers Xiaomin Chen - Chief Executive Officer and Chairman Mingze Yin - Chief Financial Officer Jing Zhang - Director Cheang I Kei - Director Mingyue Cai - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00752P203 SIC: 8071 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/26 Next Expected EPS Date: 11/18/26 Share - Related Items Shares Outstanding: 1.65 Most Recent Split Date: 2.00 (0.05:1) Beta: 0.01 Market Capitalization: $6.21 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/18/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 0.75 PEG Ratio: - Price Ratios Price/Book: 0.51 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 72.86% vs. Previous Quarter: -105.94% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -73.72 03/31/26 - 87.74 ROA 09/30/26 - - 06/30/26 - -60.36 03/31/26 - 43.65 Current Ratio 09/30/26 - - 06/30/26 - 9.33 03/31/26 - 7.38 Quick Ratio 09/30/26 - - 06/30/26 - 9.33 03/31/26 - 7.38 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - -4,906.10 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 7.43 03/31/26 - 6.66 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©